Engineered anti-IL-13 antibodies, compositions, methods and uses
US8323646B2 · kind B2 · utility
6Cited by
14References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 12, 2009 |
| Grant date | Dec 4, 2012 |
| Priority date | — |
| Expiry date | Feb 4, 2030 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/5437
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to engineered antibodies immunospecific for human interleukin-13 (IL-13) protein or fragment thereof, as well as methods of making and using thereof, including therapeutic indications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.